May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Caspase Activation in Human Corneal Epithelial Cells Using FRET
Author Affiliations & Notes
  • D.M. Robertson
    Ophthalmology, UT Southwestern Medical Center, Dallas, TX
  • W.M. Petroll
    Ophthalmology, UT Southwestern Medical Center, Dallas, TX
  • J.V. Jester
    Ophthalmology, UC, Irvine, CA
  • H.D. Cavanagh
    Ophthalmology, UT Southwestern Medical Center, Dallas, TX
  • Footnotes
    Commercial Relationships  D.M. Robertson, None; W.M. Petroll, None; J.V. Jester, None; H.D. Cavanagh, None.
  • Footnotes
    Support  NIH Grant K08 EY015713, NIH Grant EY10738 and Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 2102. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.M. Robertson, W.M. Petroll, J.V. Jester, H.D. Cavanagh; Caspase Activation in Human Corneal Epithelial Cells Using FRET . Invest. Ophthalmol. Vis. Sci. 2005;46(13):2102.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Activation of caspase 3, a cysteine protease involved in the apoptotic cascade, precedes nuclear degradation and cell death. The purpose of this experiment was to develop a fluorescence–resonance energy transfer (FRET) probe to dynamically evaluate caspase 3 activation in telomerase–immortalized human corneal epithelial (hTCEpi) cells. Methods: Enhanced yellow fluorescent protein, EYFP, was amplified from pEYFP by PCR using a forward primer containing a 4 amino acid sequence specific for the caspase 3 proteolytic cleavage site DEVD. The fragment was directionally cloned into the N terminus of an enhanced cyan fluorescent protein expression plasmid, pECFP–N1, with the resulting sequence ECFP–DEVD–EYFP. ECFP–DEVG–EYFP, a mutant substituting a Glycine for Aspartic Acid at the fourth amino acid residue and ECFP–EYFP, cleavage site omitted, were used as controls. hTCEpi cells were plated and transiently transfected using Lipofectamine. 1µM staurosporine was used to induce apoptosis. Cells were imaged using a Nikon microscope equipped with individual CFP and YFP excitation and emission filters and digitally acquired using a Photometrics CoolSnap Camera. The average regional pixel intensity for CFP and YFP emission using the CFP excitation filter was measured for each cell using MetaMorph Software and the ratio of YFP/CFP emission was calculated. Results: Prior to induction of apoptosis, ratio imaging analysis of cells transfected with either the DEVD, DEVG, or CFP–YFP FRET probe, showed a 2.43 ± 0.68 ratio of YFP/CFP emission with CFP excitation. After addition of staurosporine to activate caspase 3, the DEVD transfected cells showed a marked decrease in the ratio of YFP/CFP emission to 1.01 ± 0.06 in single cells. Cells transfected with the control FRET probes containing either the DEVG or CFP–YFP linker showed no change. Conclusions: These findings indicate that FRET can be used to study dynamic activation of caspase 3 in living hTCEpi cells. Stable cell lines expressing FRET probes for caspase 3 and the upstream effector caspase 9 will enable caspase activation to be evaluated temporally and spatially in a 4D epithelial cell culture model.

Keywords: cornea: epithelium • apoptosis/cell death • imaging/image analysis: non-clinical 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.